Vaccinia DNA
US5017487A · kind A · utility
169Cited by
4References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 1986 |
| Grant date | May 21, 1991 |
| Priority date | — |
| Expiry date | Mar 27, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/948
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New transcriptional regulatory sequences useful in the expression of pro- or eukaryotic proteins in eukaryotic organisms are provided comprising the 5' flanking region of the vaccinia virus late 11 kDa gene. Also described are recombinant vectors and recombinant infectious poxviruses containing such transcriptional regulatory sequences operatively linked to foreign genes, and live vaccines based upon these recombinant infectious poxviruses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.